• About
  • Pipeline
    • EstroTep
      • Breast Cancer
      • Metastatic Breast Cancer
      • Biomarkers’ role for treatment decision
      • Critical role of tumor heterogeneity
      • EstroTep, innovative in-vivo biomarker
      • Extensive clinical development of Fluoroestradiol
    • Z-FLD
      • Lymphoma
      • Z-FLD
      • Publications
    • LBT 999
      • Parkinson’s disease
      • LBT-999
      • Publications
  • Molecular Imaging
  • News
  • Careers
  • Contact
In-vivo biomarkers transforming oncology In-vivo biomarkers transforming oncology In-vivo biomarkers transforming oncology
  • About
  • Pipeline
    • EstroTep
      • Breast Cancer
      • Metastatic Breast Cancer
      • Biomarkers’ role for treatment decision
      • Critical role of tumor heterogeneity
      • EstroTep, innovative in-vivo biomarker
      • Extensive clinical development of Fluoroestradiol
    • Z-FLD
      • Lymphoma
      • Z-FLD
      • Publications
    • LBT 999
      • Parkinson’s disease
      • LBT-999
      • Publications
  • Molecular Imaging
  • News
  • Careers
  • Contact

Archives

Monthly Archive for: "March, 2019"
 Corinne Sulger joins Zionexa as Regulatory Affairs Manager
By Mathilde Bouscaillou
In News
Posted March 26, 2019

Corinne Sulger joins Zionexa as Regulatory Affairs Manager

Zionexa has appointed a new Regulatory Manager to drive its regulatory strategy and ensure the application of pharmaceutical regulations for the development, registration and operation of [...]

READ MORE

Menu
  • About
  • Pipeline
  • Molecular Imaging
  • News
  • Careers
  • Contact
social media
Locations
USA Zionexa c/o WeWork, 205 East 42nd Street, 20th Floor, New York, NY 10017
USA 11650 Olio Road Suite 1000 163, Fishers IN 46037
FRANCE 42 avenue de la Grande Armée 75017 Paris
FRANCE 4 allée du Groupe Nicolas Bourbaki 63170 Aubière
Copyright Zionexa © 2019 | Privacy Policy
This website uses cookies to improve your experience. Accept Read More
Privacy Policy

Necessary Always Enabled